| Systemic therapy for cardiac sarcomas. | |
| | |
MedLine Citation:
|
PMID: 20834213 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cardiac sarcomas create 2 risks: local problems and metastatic disease. Most frequently, the histologies are angiosarcoma and high-grade pleomorphic unclassified sarcoma (formerly called MFH or malignant fibrous histiocytoma). There is also a clinical-pathological entity without distinctive histological features of tumors that originate in the pulmonary artery and are referred to as pulmonary artery sarcomas or intimal sarcomas of the pulmonary artery. Conventional wisdom indicates that soft-tissue sarcomas are poorly responsive to chemotherapy. Luckily, that is not the case. Attempts to concentrate on the local problem only with therapies up to and including cardiac transplantation have been unsuccessful due to the high rate of fatal metastatic disease. |
| | |
Authors:
|
Vinod Ravi; Robert S Benjamin |
Related Documents
:
|
10187883 - Automatic embolus detection by a neural network. 2045943 - Localization and visualization of pulmonary emboli with radiolabeled fibrin-specific mo... 17426803 - Pulse wave variability within two short-term measurements. |
Publication Detail:
|
Type: Journal Article; Portraits |
Journal Detail:
|
Title: Methodist DeBakey cardiovascular journal Volume: 6 ISSN: 1947-6094 ISO Abbreviation: Methodist Debakey Cardiovasc J Publication Date: 2010 Jul-Sep |
Date Detail:
|
Created Date: 2010-09-13 Completed Date: 2010-11-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101508600 Medline TA: Methodist Debakey Cardiovasc J Country: United States |
Other Details:
|
Languages: eng Pagination: 57-60 Citation Subset: IM |
Affiliation:
|
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Agents
/
administration & dosage,
adverse effects,
therapeutic use* Heart Neoplasms / diagnosis, drug therapy* Humans Sarcoma / diagnosis, drug therapy* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Left heart sarcomas.
Next Document: RNAi screening for host factors involved in Vaccinia virus infection using Drosophila cells.